Ipamorelin research peptide — wholesale supply

For research use only · Not for human consumption · Not for veterinary use. This product is supplied for in-vitro research, analytical method development, and laboratory reference standard use only. Not approved for human or veterinary administration. Buyer is responsible for end-use classification in the destination jurisdiction.

Overview

Ipamorelin is a synthetic five-amino-acid pentapeptide research compound developed as a selective ghrelin receptor (GHS-R1a) agonist. The sequence includes an α-aminoisobutyric acid (Aib) residue at the N-terminus, a D-2-naphthylalanine (D-2Nal) residue, and a D-phenylalanine (D-Phe) residue, with an amidated C-terminus. The selective GHS-R1a profile distinguishes Ipamorelin from broader growth-hormone-releasing peptides in the same family — receptor-engagement studies, signalling pathway analysis, and analytical method development are the typical research applications. SPK Pharma India supplies Ipamorelin as a research-grade lyophilized peptide, intended for in-vitro ghrelin receptor research, growth hormone axis pathway studies, and reference-standard work.

Specifications

Research context

Ipamorelin is a well-characterised research tool in ghrelin receptor (GHS-R1a) biology. The ghrelin receptor is a Class A G-protein-coupled receptor, and the selective engagement profile of Ipamorelin — without significant off-target activity at GHRH, corticotropin-releasing factor, or somatostatin receptors — makes it a useful comparator in studies that aim to isolate the GHS-R1a contribution to downstream signalling. In-vitro receptor-binding assays, calcium-flux assays, and downstream ERK1/2 phosphorylation studies in GHS-R1a-expressing cell lines are typical research applications.

The compound is also used as a research comparator alongside broader growth-hormone-releasing peptides to characterise the contribution of the GHS-R1a pathway versus the GHRH receptor pathway in defined cell-based systems. SPK Pharma India does not make therapeutic, clinical, diagnostic, or dosing claims for this product. The compound is supplied strictly for in-vitro research, analytical method development, and reference-standard work.

For researchers new to the compound, the standard analytical reference points are CAS 170851-70-4, the five-amino-acid sequence with the Aib, D-2Nal, and D-Phe modifications, the amidated C-terminus, the calculated molecular weight of 711.85 g/mol, the lyophilized powder form, and the documented purity threshold (≥99% HPLC).

Packaging and supply

• 5 mg research vial — for method development, receptor-binding assays, and reference-standard qualification. Standard MOQ: 5 vials.
• 10 mg research vial — for ongoing research programmes with higher per-assay demand. Standard MOQ: 2 vials.
• Bulk pack — on application, for annual supply contracts and recurring orders.

Distributor pricing is available on application. Annual supply contracts with scheduled recurring dispatch are available for repeat buyers. Lead time for in-stock SKUs is typically 5 business days from purchase order confirmation; lead time for scheduled production is typically 4 to 6 weeks.

Quality and documentation

Every lot of Ipamorelin ships with a lot-matched Certificate of Analysis documenting identity (mass spectrometry and amino acid analysis), purity (HPLC), appearance, lot number, and synthesis batch reference. A representative sample of every lot is independently verified by a third-party analytical laboratory before release. MSDS is supplied with every shipment. The COA template, the lot-traceability workflow, and the third-party verification scope are documented on the Quality page.

Storage and handling

• Store at -20°C in the original sealed container.
• Protect from light and moisture.
• Allow the sealed container to reach room temperature before opening, to avoid condensation.
• Reconstitute in sterile, low-endotoxin research-grade water or in a mild buffer at the working concentration required by the assay.
• Do not refreeze once reconstituted; aliquot and store at working concentration.
• For short peptides, gentle mixing is sufficient; avoid vigorous vortexing.

Shipping

Ipamorelin is shipped lyophilized in sealed vials within temperature-validated packaging. International lanes are routed through dedicated life-science logistics partners with cold-chain handling. Standard dispatch is within 5 business days of purchase order confirmation. SPK Pharma India ships to the United States, the European Union, the United Kingdom, Canada, MENA, APAC, and LATAM. Full export documentation, including commercial invoice, packing list, certificate of origin, COA, and MSDS, is included with every shipment. Destination-specific documentation is supported on request.

Compliance

This product is supplied for research use only. It is not a drug, not a finished dosage form, and not approved for human or veterinary administration. SPK Pharma India does not make therapeutic, clinical, diagnostic, or dosing claims for this product. The buyer is responsible for end-use classification in the destination jurisdiction and for ensuring that downstream handling is consistent with research-use-only protocols.

Lead form CTA

To request a wholesale quote for Ipamorelin, contact the trade desk with the subject line "Ipamorelin wholesale quote" and your company details, expected volume, and destination country. Distributor pricing is available on application. The desk responds within one business day.

Related compounds

• CJC-1295 without DAC (Modified GRF 1-29) — 29-amino-acid GHRH analogue research peptide
• Tesamorelin — 44-amino-acid GHRH analogue research peptide
• HGH (Somatropin) — 191-amino-acid recombinant research lyophilizate
• PT-141 (Bremelanotide) — melanocortin receptor research peptide
• IGF-1 LR3 — 83-amino-acid long arginine IGF-1 research peptide